Does negative affectivity have an association with achieving target values in hypertensive patients: primary care perspective

ABSTRACT

Objectives

The current study aimed to seek the relationship between demographic characteristics, treatment compliance status, and type D personality characteristics to achieve target BP values.

Methods

This cross-sectional research was conducted on HT patients at three family medicine health-care services in Ankara, Turkey, between 1 February 2021, and 31 January 2022. The sociodemographic questionnaire survey, Hill-Bone Compliance to High Blood Pressure Therapy Scale (HBCHBPTS), and Type D Scale-14 (DS-14) were applied to 317 patients. HBCHBPTS consists of 14 items with three domains. DS-14 consists of 14 items assessing negative affectivity (NA) and social inhibition (SI).

Results

Patients with NA were less likely to achieve the SBP target values (62.20% vs 47.50, p = 0.011). NA scores were correlated with HBCHBPTS total scores and HBCHBPTS medication-taking domain scores. Living in a city center (β = −0.157, p = 0.017), not smoking (β = −0.114, p = 0.042), knowing the names of HT drugs (β = - 0.152, p = 0.005), having a Mediterranean-style diet (β = −0.182, p = 0.002), starting treatment immediately after diagnosis (β = −0.121, p = 0.029), older age (β = −0.164, p = 0.028), having less NA scores (β = 0.171, p = 0.029) were effective on better treatment adherence. Variables affecting the failure to achieve the SBP target values were not being in the extended family (p = 0.022, OR: 0.337), anti-HT drug side effects (p = 0.029, OR: 2.566), higher HBCHBPTS total scores (p = 0.001, OR: 1.178), higher DBP values (p < 0.001, OR: 1.141).

Conclusion

HBCHBPTS total and HBCHBPTS medication-taking domain indicators worsened as the NA and SI characteristics increased. Predictors, including those not living in an extended family, being affected by the side effects of anti-HT drugs, high HBCHBPTS total score, and high DBP values, were effective in failure to achieve the SBP target values.

KEYWORDS:

• Hypertension
• treatment adherence and compliance
• type D personality

Author contributions

Yusuf Cetin Doganer: conceptualization, methodology, investigation, visualization, resources, writing-original draft preparation, reviewing, and editing; Ebru Esra Yalcin: methodology, software, formal analysis, data curation, validation, writing-original draft preparation; Umit Aydogan: design, investigation, visualization, reviewing, and editing; Halil Dogrul: software, formal analysis, data curation, writing-original draft preparation; Muhammet Bereket: design, acquisition of data, interpretation of data; and Melih Karamuk: design, acquisition of data, interpretation of data, reviewing, and editing.

Declaration of funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Declaration of financial/other relationships

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

Peer reviewers in this manuscript have no relevant financial or other relationships to disclose.